Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 1, 2008, Pages

  Aoki, Masayo ^a   Terada, Tomohiro ^a   Kajiwara, Moto ^a   Ogasawara, Ken ^a   Ikai, Iwao ^a   Ogawa, Osamu ^a   Katsura, Toshiya ^a   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Drug transporter; Epigenetics; Renal secretion; Tissue specific gene expression

Indexed keywords

BISULFITE; DNA; LUCIFERASE; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 1; ORGANIC CATION TRANSPORTER 2; UPSTREAM STIMULATORY FACTOR 1; ORGANIC CATION TRANSPORTER; POU2F1 PROTEIN, HUMAN; SLC22A2 PROTEIN, HUMAN; UPSTREAM STIMULATORY FACTOR; USF1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA EXTRACTION; DNA METHYLATION; E BOX ELEMENT; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; BIOSYNTHESIS; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; KIDNEY; LIVER; MALE; METABOLISM; PHYSIOLOGY;

DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; LIVER; MALE; OCTAMER TRANSCRIPTION FACTOR-1; ORGANIC CATION TRANSPORT PROTEINS; PROMOTER REGIONS (GENETICS); UPSTREAM STIMULATORY FACTORS;

EID: 49949105228     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90257.2008     Document Type: Article

References (31)

1. Akintola AD, Crislip ZL, Catania JM, Chen G, Zimmer WE, Burghardt RC, Parrish AR. Promoter methylation is associated with the age-dependent loss of N-cadherin in the rat kidney. Am J Physiol Renal Physiol 294: F170-F176, 2008.
2. Asaka J, Terada T, Ogasawara K, Katsura T, Inui K. Characterization of the basal promoter element of human organic cation transporter 2 gene. J Pharmacol Exp Ther 321: 684-689, 2007.
3. Asaka J, Terada T, Okuda M, Katsura T, Inui K. Androgen receptor is responsible for rat organic cation transporter 2 gene regulation but not for rOCT1 and rOCT3. Pharm Res 23: 697-704, 2006.
4. Bell AC, Felsenfeld G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405: 482-485, 2000.
5. Bird AP, Wolffe AP. Methylation-induced repression- belts, braces, and chromatin. Cell 99: 451-454, 1999.
6. Cereghini S. Liver-enriched transcription factors and hepatocyte differentiation. FASEB J 10: 267-282, 1996.
7. Ciarimboli G, Ludwig T, Lang D, Pavenstadt H, Koepsell H, Piechota HJ, Haier J, Jaehde U, Zisowsky J, Schlatter E. Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. Am J Pathol 167: 1477-1484, 2005.
8. Comb M, Goodman HM. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res 18: 3975-3982, 1990.
9. Costello JF, Plass C. Methylation matters. J Med Genet 38: 285-303, 2001.
10. Douet V, Heller MB, Le Saux O. DNA methylation and Sp1 binding determine the tissue-specific transcriptional activity of the mouse Abcc6 promoter. Biochem Biophys Res Commun 354: 66-71, 2007.
11. Fujita T, Urban TJ, Leabman MK, Fujita K, Giacomini KM. Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants. J Pharm Sci 95: 25-36, 2006.
12. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Busch AE, Koepsell H. Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16: 871-881, 1997.
13. Inui K, Masuda S, Saito H. Cellular and molecular aspects of drug transport in the kidney. Kidney Int 58: 944-958, 2000.
14. Jonker JW, Schinkel AH. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J Pharmacol Exp Ther 308: 2-9, 2004.
15. Jover R, Bort R, Gomez-Lechon MJ, Castell JV. Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting. Hepatology 33: 668-675, 2001.
16. Kikuchi R, Kusuhara H, Hattori N, Kim I, Shiota K, Gonzalez FJ, Sugiyama Y. Regulation of tissue-specific expression of the human and mouse urate transporter 1 gene by hepatocyte nuclear factor 1 α/β and DNA methylation. Mol Pharmacol 72: 1619-1625, 2007.
17. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31: 89-97, 2006.
18. Motohashi H, Sakurai Y, Saito H, Masuda S, Urakami Y, Goto M, Fukatsu A, Ogawa O, Inui K. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol 13: 866-874, 2002.
19. Ogasawara K, Terada T, Motohashi H, Asaka J, Aoki M, Katsura T, Kamba T, Ogawa O, Inui K. Analyses of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidney. J Hum Genet. doi:10/1007/s10038-008-0288-9.
20. Popowski K, Eloranta JJ, Saborowski M, Fried M, Meier PJ, Kullak-Ublick GA. The human organic anion transporter 2 gene is transactivated by hepatocyte nuclear factor-4α and suppressed by bile acids. Mol Pharmacol 67: 1629-1638, 2005.
21. Prendergast GC, Lawe D, Ziff EB. Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 65: 395-407, 1991.
22. Saborowski M, Kullak-Ublick GA, Eloranta JJ. The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4α. J Pharmacol Exp Ther 317: 778-785, 2006.
23. Salozhin SV, Prokhorchuk EB, Georgiev GP. Methylation of DNA - one of the major epigenetic markers. Biochemistry (Mosc) 70: 525-532, 2005.
24. Shimakura J, Terada T, Katsura T, Inui K. Characterization of the human peptide transporter PEPT1 promoter: Sp1 functions as a basal transcriptional regulator of human PEPT1. Am J Physiol Gastrointest Liver Physiol 289: G471-G477, 2005.
25. Shimakura J, Terada T, Shimada Y, Katsura T, Inui K. The transcription factor Cdx2 regulates the intestine-specific expression of human peptide transporter 1 through functional interaction with Sp1. Biochem Pharmacol 71: 1581-1588, 2006.
26. Sirito M, Lin Q, Maity T, Sawadogo M. Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells. Nucleic Acids Res 22: 427-433, 1994.
27. Sladek FM, Zhong WM, Lai E, Darnell JE Jr. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 4: 2353-2365, 1990.
28. Weih F, Nitsch D, Reik A, Schutz G, Becker PB. Analysis of CpG methylation and genomic footprinting at the tyrosine aminotransferase gene: DNA methylation alone is not sufficient to prevent protein binding in vivo. EMBO J 10: 2559-2567, 1991.
29. Yokoo S, Yonezawa A, Masuda S, Fukatsu A, Katsura T, Inui K. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity. Biochem Pharmacol 74: 477-487, 2007.
30. Yonezawa A, Masuda S, Nishihara K, Yano I, Katsura T, Inui K. Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat. Biochem Pharmacol 70: 1823-1831, 2005.
31. Yonezawa A, Masuda S, Yokoo S, Katsura T, Inui K. Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family). J Pharmacol Exp Ther 319: 879-886, 2006.